Mice treated with targeted ANC@RNP/crEGFR‐PLK1 nanocapsules exhibited potent inhibition of tumor growth after five RNP doses, as evidenced by showing the weakest bioluminescence intensity (Figure 4b,c). The gene discussed is PLK1; the disease is neoplasm.